GeneDx Holdings Corp (WGS)
20.87
+3.80
(+22.26%)
USD |
NASDAQ |
May 01, 16:00
20.32
-0.55
(-2.64%)
Pre-Market: 08:07
GeneDx Holdings Debt to Equity Ratio: 0.2524 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.2524 |
| December 31, 2023 | 0.2333 |
| September 30, 2023 | 0.0246 |
| June 30, 2023 | 0.0211 |
| March 31, 2023 | 0.019 |
| December 31, 2022 | 0.0434 |
| September 30, 2022 | 0.019 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.0173 |
| March 31, 2022 | 0.0334 |
| December 31, 2021 | 0.0283 |
| September 30, 2021 | 0.0281 |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -0.0628 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.0628
Minimum
Dec 2020
0.2524
Maximum
Mar 2024
0.0548
Average
0.0263
Median
Debt to Equity Ratio Benchmarks
| American Well Corp | 0.00 |
| GoodRx Holdings Inc | 0.8616 |
| Privia Health Group Inc | 0.00 |
| Doximity Inc | 0.00 |
| FOXO Technologies Inc | -0.3608 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 394.53M |
| Total Liabilities (Quarterly) | 187.31M |
| Shareholders Equity (Quarterly) | 207.22M |
| Current Ratio | 3.221 |
| Net Debt Paydown Yield | -3.46% |